Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Articles published by Catalyst Pharmaceuticals, Inc.

Catalyst Pharmaceuticals Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Business Update
From Catalyst Pharmaceuticals, Inc.
Via Globe NewsWire
Tickers CPRX
Catalyst Pharmaceuticals Announces a Recent Third-Party Publication in Peer-Reviewed Journal Epilepsia Showing Perampanel (FYCOMPA®) Demonstrated High Efficacy in Patients with Rare Genetic Epilepsies
From Catalyst Pharmaceuticals, Inc.
Via Globe NewsWire
Tickers CPRX
Catalyst Pharmaceuticals to Report Fourth Quarter and Full-Year 2022 Financial Results on March 15, 2023
From Catalyst Pharmaceuticals, Inc.
Via Globe NewsWire
Tickers CPRX
Catalyst Pharmaceuticals to Ring the Nasdaq Closing Bell in Honor of International Rare Disease Day
From Catalyst Pharmaceuticals, Inc.
Via Globe NewsWire
Tickers CPRX
Catalyst Pharmaceuticals Reports Preliminary Fourth Quarter and Full Year 2022 Total Revenues and Provides Full Year 2023 Revenue Guidance
From Catalyst Pharmaceuticals, Inc.
Via Globe NewsWire
Tickers CPRX
Catalyst Pharmaceuticals Completes the Acquisition of U.S. Rights to FYCOMPA® (Perampanel) CIII
From Catalyst Pharmaceuticals, Inc.
Via Globe NewsWire
Tickers CPRX
Catalyst Pharmaceuticals Comments on FDA's Announcement of its Position on Orphan Drug Exclusivity In Light of the 11th Circuit Decision in Catalyst Pharmaceuticals, Inc. v. Becerra
From Catalyst Pharmaceuticals, Inc.
Via Globe NewsWire
Tickers CPRX
Catalyst Pharmaceuticals Notified of Abbreviated New Drug Application Filing for FIRDAPSE®
From Catalyst Pharmaceuticals, Inc.
Via Globe NewsWire
Tickers CPRX
Catalyst Pharmaceuticals to Acquire U.S. Commercial Rights to FYCOMPA® (Perampanel) CIII From Eisai Co., Ltd
From Catalyst Pharmaceuticals, Inc.
Via Globe NewsWire
Tickers CPRX
Catalyst Pharmaceuticals Reports Record Third Quarter 2022 Financial Results and Provides a Corporate Update
From Catalyst Pharmaceuticals, Inc.
Via Globe NewsWire
Tickers CPRX
Catalyst Pharmaceuticals Named BioFlorida 2022 Company of the Year
From Catalyst Pharmaceuticals, Inc.
Via Globe NewsWire
Tickers CPRX
Catalyst Pharmaceuticals to Report Third Quarter 2022 Financial Results on November 9, 2022
From Catalyst Pharmaceuticals, Inc.
Via Globe NewsWire
Tickers CPRX
Catalyst Pharmaceuticals Announces FDA Approval of Supplemental New Drug Application for FIRDAPSE® Expanding Patient Population to Include Pediatric Patients
From Catalyst Pharmaceuticals, Inc.
Via Globe NewsWire
Tickers CPRX
Catalyst Pharmaceuticals to Report Second Quarter 2022 Financial Results on August 9, 2022
From Catalyst Pharmaceuticals, Inc.
Via Globe NewsWire
Tickers CPRX
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.